Feryel Soualmia

Title: Feryel Soualmia: Innovator in Neurodegenerative Disease Treatment

Introduction

Feryel Soualmia is a prominent inventor based in Saint Mande, France. She has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative and inflammatory diseases. Her innovative work has led to the development of a patent that showcases her expertise and dedication to improving health outcomes.

Latest Patents

Feryel Soualmia holds a patent for "Compounds and compositions for the treatment of neurodegenerative and inflammatory diseases." This invention relates to compounds exhibiting kallikrein inhibitory activity. The compositions she developed are intended for use in treating diseases or disorders where kallikrein activity is dysregulated, particularly focusing on neurodegenerative and inflammatory conditions. She has 1 patent to her name.

Career Highlights

Throughout her career, Feryel has worked with esteemed institutions such as Sorbonne Université and the Centre National de la Recherche Scientifique. Her roles in these organizations have allowed her to collaborate with leading researchers and contribute to groundbreaking studies in her field.

Collaborations

Feryel has collaborated with notable colleagues, including Chahrazade El Amri and Nicolas Masurier. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Feryel Soualmia is a trailblazer in the field of neurodegenerative disease treatment, with a focus on innovative compounds that address critical health issues. Her contributions continue to influence the medical community and pave the way for future advancements.